Dataset Information

De novo mutations in PURA are associated with hypotonia and developmental delay.

ABSTRACT: PURA is the leading candidate gene responsible for the developmental phenotype in the 5q31.3 microdeletion syndrome. De novo mutations in PURA were recently reported in 15 individuals with developmental features similar to the 5q31.3 microdeletion syndrome. Here we describe six unrelated children who were identified by clinical whole-exome sequencing (WES) to have novel de novo variants in PURA with a similar phenotype of hypotonia and developmental delay and frequently associated with seizures. The protein Pur? (encoded by PURA) is involved in neuronal proliferation, dendrite maturation, and the transport of mRNA to translation sites during neuronal development. Mutations in PURA may alter normal brain development and impair neuronal function, leading to developmental delay and the seizures observed in patients with mutations in PURA.

SUBMITTER: Tanaka AJ

PROVIDER: S-EPMC4850890 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

De novo mutations in PURA are associated with hypotonia and developmental delay.

Tanaka Akemi J AJ Bai Renkui R Cho Megan T MT Anyane-Yeboa Kwame K Ahimaz Priyanka P Wilson Ashley L AL Kendall Fran F Hay Beverly B Moss Timothy T Nardini Monica M Bauer Mislen M Retterer Kyle K Juusola Jane J Chung Wendy K WK

Cold Spring Harbor molecular case studies 20151001 1

PURA is the leading candidate gene responsible for the developmental phenotype in the 5q31.3 microdeletion syndrome. De novo mutations in PURA were recently reported in 15 individuals with developmental features similar to the 5q31.3 microdeletion syndrome. Here we describe six unrelated children who were identified by clinical whole-exome sequencing (WES) to have novel de novo variants in PURA with a similar phenotype of hypotonia and developmental delay and frequently associated with seizures. ...[more]

PMID: 27148565

Dataset Information

De novo mutations in PURA are associated with hypotonia and developmental delay.

Publications

De novo mutations in PURA are associated with hypotonia and developmental delay.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Similar Datasets

De novo variants in EBF3 are associated with hypotonia, developmental delay, intellectual disability, and autism.
| S-EPMC5701309 | biostudies-literature

A de novo missense mutation in ZMYND11 is associated with global developmental delay, seizures, and hypotonia.
| S-EPMC5002929 | biostudies-literature

De novo mutations in NALCN cause a syndrome characterized by congenital contractures of the limbs and face, hypotonia, and developmental delay.
| S-EPMC4375444 | biostudies-literature

De novo truncating mutations in AHDC1 in individuals with syndromic expressive language delay, hypotonia, and sleep apnea.
| S-EPMC4067559 | biostudies-literature

Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability.
| S-EPMC4251168 | biostudies-literature

A de novo TOP2B variant associated with global developmental delay and autism spectrum disorder.
| S-EPMC7057084 | biostudies-literature

Inherited and multiple de novo mutations in autism/developmental delay risk genes suggest a multifactorial model.
| S-EPMC6293633 | biostudies-literature

Variants in DOCK3 cause developmental delay and hypotonia.
| S-EPMC6777627 | biostudies-literature

Germline De Novo Mutations in GNB1 Cause Severe Neurodevelopmental Disability, Hypotonia, and Seizures.
| S-EPMC4863562 | biostudies-literature

De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation.
| S-EPMC7118694 | biostudies-literature